Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2019 Jul 26.
Published in final edited form as: Arterioscler Thromb Vasc Biol. 2006 May 4;26(7):1674–1679. doi: 10.1161/01.ATV.0000225701.20965.b9

Dietary Factors Related to Higher Plasma Fibrinogen Levels of Japanese-Americans in Hawaii Compared With Japanese in Japan

Katsuyuki Miura 1, Hideaki Nakagawa 2, Hirotsugu Ueshima 3, Akira Okayama 4, Shigeyuki Saitoh 5, J David Curb 6, Beatriz L Rodriguez 7, Kiyomi Sakata 8, Nagako Okuda 9, Katsushi Yoshita 10, Jeremiah Stamler 11, INTERMAP and INTERLIPID Research Groups
PMCID: PMC6660157  NIHMSID: NIHMS1033084  PMID: 16675719

Abstract

Objective

We investigated whether dietary factors explain higher plasma fibrinogen levels in Japanese emigrants living a Western lifestyle in Hawaii compared with Japanese in Japan.

Methods and Results

Plasma fibrinogen and nutrient intakes were examined by standardized methods in men and women 40 to 59 years of age from a Japanese-American sample in Hawaii (100 men and 106 women) and 4 population samples in Japan (569 men and 567 women). Multiple linear regression models were used to examine the relationship between dietary factors and the plasma fibrinogen difference between Hawaii and Japan. Average plasma fibrinogen was significantly higher in Hawaii compared with Japan (P<0.001 in both genders). In multiple linear regression analyses with each dietary variable considered separately, body mass index reduced the plasma fibrinogen difference between Hawaii and Japan by 20.4%; iron intake (mg/1000 kcal) and estimated total sugar intake (%kcal) reduced this difference by 30.0% and 14.4%, respectively. In a model that included body mass index, iron, estimated total sugars, and caffeine (also age and gender), this difference was reduced by 61.3% (from 42.2 to 16.3 mg/dL).

Conclusions

Higher intake of iron, sugar, and caffeine, in addition to obesity, account largely for higher fibrinogen levels with Westernized lifestyle.

Keywords: fibrinogen, nutrition, iron, sugar, caffeine, obesity, population study


Japanese living in Japan have lower rates of coronary heart disease (CHD) than people in the United States and other Western countries,1,2 including Japanese-Americans living in Hawaii.3,4 In recent decades, these trends appear to have continued despite higher smoking rates, higher blood pressure levels, and increasing serum cholesterol levels in Japan with a more Westernized lifestyle.1,5 Investigation of factors possibly affecting the CHD risk difference among genetically similar Japanese populations living in Japan and Hawaii is of interest in understanding these differences.

Elevated plasma fibrinogen level has been identified as a risk factor for CHD and stroke in both Western and Japanese populations.68 A previous study found plasma fibrinogen levels among 75- to 93-year-old Japanese men living in Japan to be significantly lower than those among Japanese of similar age living in Hawaii.9 Factors contributing to this difference remain unclear; few data are available on the role of dietary factors.

Here we report standardized comparisons of plasma fibrinogen and dietary factors between Japanese living in Japan and Japanese-Americans living a primarily Western lifestyle in Hawaii, from the INTERLIPID study, an ancillary investigation of the INTERMAP study on diet and blood pressure. We assessed whether dietary factors account for the difference in fibrinogen levels.

Methods

INTERMAP is an international cooperative study on relationships between multiple dietary factors and blood pressure among 4680 participants 40 to 59 years of age from 17 diverse population samples in China, Japan, the United Kingdom, and the United States. INTERLIPID is an INTERMAP ancillary study focused mainly on relationships of these factors to serum lipids, blood analytes, and other factors in Japanese participants from Japan and Hawaii. Detailed methods of these 2 studies have been described previously,1012 and they are summarized below. Participants were men and women 40 to 59 years of age, recruited as random samples by 5 research centers, 4 in Japan, and 1 in Hawaii. Plasma fibrinogen was measured in 569 men and 567 women in Japan and in 100 men and 106 women in Hawaii. The ethical committees of the Shiga University of Medical Science, the Sapporo Medical University, the Kanazawa Medical University, the Wakayama Medical University, and the Pacific Health Research Institute approved the study protocol. Written informed consent was obtained from all participants.

Medical and lifestyle information, 4 in-depth 24-hour dietary recalls, and 2 timed 24-hour urine collections were obtained from each participant. For the INTERLIPID study, nonfasting blood was drawn; serum and plasma were centrifuged within 30 minutes and were stored immediately under refrigeration. Plasma fibrinogen, serum lipids, HbA1c, and other variables were measured in a central laboratory ≈6 to 12 months later. The thrombin coagulation time method was used to measure plasma fibrinogen concentration.

The 4 24-hour dietary recalls were conducted with each participant at 4 visits by specially trained dietary interviewers. Standardized quality control procedures were adopted to assess and maximize quality of dietary data throughout the data collection.11,13 Nutrient intakes of individual participants are means of the 4 dietary recalls. Dietary data are expressed as nutrient densities as percent total kilocalories (kcal from nutrient/total kcal) × 100 for nutrients supplying energy and as nutrients per 1000 kcal (amount per 24 hours/total kcal)×1000 for other nutrients.

For descriptive purpose, means and SDs or percentages were calculated for the Hawaii and Japan samples, with t tests or χ2 tests for Hawaii-Japan comparisons. Based on significant differences between Hawaii and Japan for individual nondietary and dietary variables, multiple linear regression models were used to examine relationships between dietary factors and the difference in plasma fibrinogen levels between Hawaii and Japan, with control for age, gender, body mass index (BMI), and current smoking. The basic model (model 1) included age, gender, and an indicator for Hawaii to obtain the age-gender-adjusted coefficient for the fibrinogen difference. Each factor was then added to model 1 separately, and percentage reduction from the model 1 coefficient was calculated to assess influence of the added variable on the fibrinogen difference. These models were computed with and without inclusion of BMI and current smoking (no, yes). Finally, dietary and nondietary variables were included in combinations to assess their joint impact on the fibrinogen difference. From 17 (of 41) dietary and nondietary variables that changed the fibrinogen difference by >5%, 9 variables were selected by the stepwise selection method (P<0.15) for multiple linear regression. This stepwise method is a modification of the forward-selection technique and differs in that variables already in the model do not necessarily stay there. These 9 variables were added successively 1 by 1 to model 1 to assess overall percentage reduction in the model 1 coefficient.

Results

Descriptive Statistics

Average age and height were similar for participants from Japan and Hawaii for each gender (Table 1). Average BMI was significantly higher in Hawaii than Japan (4.8 U higher in men; 2.5 U higher in women). Mean plasma fibrinogen concentration was significantly higher in Hawaii than Japan (34.1 mg/dL higher in men and 52.0 mg/dL higher in women). Serum total cholesterol, low-density lipoprotein cholesterol, and HbA1c were all significantly higher in Hawaii than Japan. Urinary timed 24-hour sodium and Na/K ratio were significantly higher in Japan than Hawaii. Percentage of current smokers among men was much higher in Japan than Hawaii. Some of these data are published.12

TABLE 1.

Descriptive Statistics, Japanese in Japan and Japanese-Americans in Hawaii, by Gender

Men
Women
Variable Japan Hawaii P* Japan Hawaii P*
No. of participants 569 100 567 106
Age, y 49.5±5.3 50.6±5.2 0.078 49.2±5.3 49.8±4.9 0.332
Height, m 1.68±0.06 1.67±0.06 0.308 1.55±0.06 1.54±0.05 0.088
Weight, kg 66.9±8.8 80.0±14.7 <0.001 55.5±8.0 60.8±12.6 <0.001
Body mass index, kg/m2 23.7±2.7 28.5±4.6 <0.001 23.2±3.1 25.7±5.4 <0.001
Systolic blood pressure, mm Hg 120.4±12.9 119.0±11.8 0.329 114.1±14.0 115.2±13.7 0.451
Diastolic blood pressure, mm Hg 76.8±10.0 74.7±8.6 0.054 70.5±9.6 70.1±8.8 0.663
Fibrinogen, mg/dL 253.7±69.0 287.8±57.8 <0.001 258.6±65.3 310.6±60.6 <0.001
Serum total cholesterol, mg/dL 199.3±28.8 209.8±29.0 <0.001 202.2±30.7 211.5±32.2 0.005
HDL cholesterol, mg/dL 53.7±13.7 50.2±10.2 0.014 60.0±14.2 59.7±13.2 0.827
LDL cholesterol, mg/dL 120.4±28.6 134.1±28.2 <0.001 123.9±29.9 137.0±33.5 <0.001
HbA1c, % 4.8±0.6 5.0±0.8 <0.001 4.6±0.4 4.7±0.7 0.003
Urinary sodium, mmol/24 hours 210.4±56.6 174.4±52.3 <0.001 186.1±53.2 133.5±44.6 <0.001
Urinary potassium, mmol/24 hours 49±13 55±16 <0.001 48±14 42±13 <0.001
Urinary Na/K ratio 4.5±1.3 3.4±1.2 <0.001 4.1±1.2 3.4±1.1 <0.001
Education, years 12.3±2.1 15.4±2.5 <0.001 11.6±2.0 15.6±2.3 <0.001
History of CVD, % 1.2 3.0 0.179 0.4 0.9 0.402
Drug treatment for hypertension, % 6.0 28.0 <0.001 6.5 24.5 <0.001
Taking vitamin/mineral supplements, % 23.6 58.0 <0.001 23.6 76.4 <0.001
On any special diet, % 5.5 12.0 0.014 7.9 20.8 <0.001
Hours of heavy or moderate physical activity, hours/24 hours 2.5±3.6 2.2±2.7 0.348 2.6±3.5 1.1±1.6 <0.001
Current smoker, % 51.7 10.0 <0.001 8.6 4.7 0.172
No. of cigarettes per day, smokers 22.6±9.3 14.2±10.6 0.006 11.5±7.0 13.0±7.6 0.646

Values are means±SD or percentage (prevalence).

*

P values for Japan vs Hawaii by t test or χ2 test.

CVD indicates cardiovascular disease; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

Mean intake of most nutrient variables differed significantly between Hawaii and Japan (Table 2). Total energy intake was significantly higher in Hawaii than in Japan in men but not women. Men and women in Hawaii reported significantly higher intakes of animal protein, total fat, saturated fatty acids, monounsaturated fatty acids, polyunsaturated fatty acids (PFA), omega-6 fatty acids, trans fatty acids, estimated total sugars, vitamin A, beta carotene, magnesium, iron, and caffeine. Men and women in Hawaii reported significantly lower average intakes of vegetable protein, omega-3 fatty acids, dietary cholesterol, ratio PFA/ saturated fatty acids, total available carbohydrates, starch, alcohol, vitamin E, and selenium.

TABLE 2.

Nutrient Intake, Japanese in Japan and Japanese-Americans in Hawaii by Gender

Variable Men
Women
Japan Hawaii P* Japan Hawaii P*
Energy, kcal/day 2280±428 2427±613 0.003 1797±324 1765±391 0.369
Total protein, %kcal 15.8±2.3 17.2±2.9 <0.001 16.1±2.3 16.6±3.0 0.091
Animal protein, %kcal 8.9±2.5 11.1±3.2 <0.001 8.8±2.4 10.4±3.5 <0.001
Vegetable protein, %kcal 6.9±1.1 5.9±1.5 <0.001 7.3±1.1 6.1±1.8 <0.001
Total fat, %kcal 23.7±4.8 31.9±6.3 <0.001 26.1±4.9 31.9±7.7 <0.001
SFA, %kcal 6.1±1.6 9.1±2.2 <0.001 7.1±1.8 9.4±2.7 <0.001
MFA, %kcal 8.6±2.1 11.9±2.8 <0.001 9.4±2.2 11.7±3.6 <0.001
PFA, %kcal 6.2±1.5 7.5±1.8 <0.001 6.6±1.4 7.5±2.3 <0.001
PFA/SFA ratio 1.1±0.3 0.9±0.2 <0.001 1.0±0.3 0.9±0.3 <0.001
Omega-3 PFA, %kcal 1.3±0.4 0.9±0.3 <0.001 1.4±0.4 0.9±0.3 <0.001
Omega-6 PFA, %kcal 4.8±1.3 6.8±1.7 <0.001 5.2±1.3 6.7±2.1 <0.001
Total trans fatty acid, %kcal 0.3±0.2 1.5±0.6 <0.001 0.5±0.3 1.6±0.7 <0.001
Cholesterol, mg/1000 kcal 195.7±7.4 128.9±49.4 <0.001 198.7±66.7 134.0±57.8 <0.001
Keys dietary lipid score 28.7±6.0 31.2± 7.6 <0.001 31.0±6.5 32.2±9.5 0.111
Total available carbohydrate, %kcal 52.2±7.7 48.1±7.6 <0.001 56.2±6.4 50.9±8.7 <0.001
Starch, %kcal 35.4±8.0 26.6±5.5 <0.001 35.6±6.5 27.6±6.6 <0.001
Total dietary fiber, g/1000 kcal 6.9±1.9 8.3±2.3 <0.001 8.9±2.3 9.1±3.5 0.474
Estimated total sugars, %kcal 13.2±3.8 20.1±7.2 <0.001 15.9±4.1 21.8±6.5 <0.001
Alcohol, g/day 28.0±25.7 10.0±15.8 <0.001 4.0±8.3 1.4±4.0 0.002
Vitamin A, IU/1000 kcal 2760±1851 4079±2772 <0.001 3526±2034 5074±4161 <0.001
Retinol, mcg/1000 kcal 182.9±361.6 133.0±104.0 0.171 177.2±236.6 178.0±244.9 0.974
Beta-carotene, mcg/1000 kcal 1290±877 2178±1636 <0.001 1762±1162 2684±2499 <0.001
Vitamin C, mg/1000 kcal 56.3±36.1 58.6±37.0 0.564 75.3±40.8 63.7±37.1 0.007
Total vitamin E, mg ATE/1000 kcal 4.6±1.0 4.3±1.2 0.012 5.3±1.6 4.6±1.8 <0.001
Calcium, mg/1000 kcal 270.1±91.5 277.1±118.9 0.502 341.2±113.0 301.8±111.4 0.001
Magnesium, mg/1000 kcal 128.0±23.4 166.7±45.3 <0.001 140.9±25.3 161.7±42.6 <0.001
Iron, mg/1000 kcal 5.1±1.1 8.5±2.0 <0.001 5.6±1.1 8.7±2.1 <0.001
Phosphorus, mg/1000 kcal 545±89 585±118 <0.001 580±97 576±95 0.680
Selenium, mcg/1000 kcal 84.7±32.9 73.6±15.0 0.001 84.7±32.2 71.1±15.4 <0.001
Caffeine, mg/1000 kcal 69.7±50.9 108.0±89.8 <0.001 67.6±43.8 100.9±94.8 <0.001

Values are means±SD.

SFA indicates saturated fatty acids; MFA, monounsaturated fatty acids; total available carbohydrate, exclusive of dietary fiber; estimated total sugars, total available carbohydrate minus starch; ATE, alpha-tocopherol equivalents.

*

P values for Japan vs Hawaii by t test.

Relation of Single Dietary Variables to the Fibrinogen Difference

With adjustment for age and gender in multiple regression analyses, plasma fibrinogen in Hawaii was higher than in Japan by 42.2 mg/dL (P<0.001) and by 37.1 mg/dL (P<0.001) in models with and without adjustment for BMI and current smoking, respectively (model 1; Table 3). Among 9 non-nutrient variables, 3 (BMI, current smoking, and education) changed the fibrinogen difference by >5% (Table 3). The fibrinogen difference was reduced by 20.4% with BMI in the model (model 2; Table 3) and was increased by 8.7% with current smoking in the model (model 3; Table 3).

TABLE 3.

Relation of Variables Considered Singly to Hawaii–Japan Difference in Plasma Fibrinogen

Model Variables in Multiple Linear Regression Model Model Without BMI and Current Smoking Model With BMI and Current Smoking
1 Site (Hawaii/Japan), age, gender 42.2* (<0.001) 37.1 (<0.001)
−12.0%
2 Model 1+BMI, kg/m2 33.6 (<0.001)
−20.4%
3 Model 1 +current smoking (no, yes) 45.8 (<0.001)
+8.7%
4 Model 1 +education, years 41.0 (<0.001) 34.8 (<0.001)
−2.7% −6.3%§
5 Model 1 +urinary sodium, mmol/24 hours 42.3 (<0.001) 34.1 (<0.001)
+0.2% −8.1%§
6 Model 1 +urinary Na/K ratio 40.4 (<0.001) 33.7 (<0.001)
−4.1% −9.2%§
7 Model 1 +omega-3 PFA, %kcal 44.4 (<0.001) 38.6 (<0.001)
+5.3% +4.0%§
8 Model 1+cholesterol, mg/1000 kcal 45.1 (<0.001) 39.5 (<0.001)
+7.0% +6.5%§
9 Model 1 +starch, %kcal 39.7 (<0.001) 35.4 (<0.001)
−5.9% −4.6%§
10 Model 1 +estimated total sugars, %kcal 38.1 (<0.001) 31.8 (<0.001)
−9.7% −14.4%§
11 Model 1+magnesium, mg/1000 kcal 40.9 (<0.001) 34.4 (<0.001)
−3.0% −7.2%§
12 Model 1+iron, mg/1000 kcal 32.8 (<0.001) 26.0 (<0.001)
−22.2% −30.0%§
13 Model 1+vitamin A, IU/1000 kcal 40.6 (<0.001) 35.1 (<0.001)
−3.7% −5.4%§
14 Model 1+beta-carotene, mcg/1000 kcal 40.3 (<0.001) 34.5 (<0.001)
−4.4% −7.1%§
15 Model 1+caffeine, mg/1000 kcal 39.7 (<0.001) 34.8 (<0.001)
−5.9% −6.3%§
*

Coefficient for difference in fibrinogen (mg/dL) between Hawaii and Japan

P value for site-fibrinogen coefficient

percent change in site-fibrinogen coefficient compared with model 1 without BMI and smoking

§

percent change in site-fibrinogen coefficient compared with model 1 with BMI and smoking.

Detailed data not shown for variables influencing fibrinogen coefficient <5.0%.

Thirty-two dietary variables were included singly in the model; 11 dietary variables changed the fibrinogen difference by >5% in models with or without BMI and current smoking (Table 3). Among dietary variables, iron intake produced the largest reduction in the fibrinogen difference (model 12; Table 3). Several other variables produced reductions in the fibrinogen difference of 5% or more: estimated total sugars, starch, magnesium, vitamin A, beta carotene, caffeine, and urinary Na and Na/K ratio. Omega-3 PFA and dietary cholesterol increased the fibrinogen difference.

Relation of Combinations of Dietary Variables to the Fibrinogen Difference

The stepwise selection method of multiple linear regression was done using site, age, gender, and 14 other variables (Table 3); each of these considered singly changed the fibrinogen difference by >5%. Nine variables, site, age, gender, BMI, iron, estimated total sugars, caffeine, current smoking, and urinary Na/K ratio, were selected at the 0.15 significance level. In this model, the site-fibrinogen coefficient (the fibrinogen difference) was 17.9 mg/dL (ie, reduced by 57.6% from the model 1 coefficient, with only age and gender [model 6; Table 4]). Two of these variables, current smoking and urinary Na/K ratio, increased the site-fibrinogen coefficient. With step-by-step addition of 7 other variables into the multiple linear regression model, the site-fibrinogen coefficient was gradually reduced from 42.2 mg/dL (model 1; Table 4) to 16.3 mg/dL (model 5; Table 4). Model 5 showed that inclusion of BMI, iron, estimated total sugar, and caffeine reduced the fibrinogen difference by 61.3%; this smaller difference was still significant (P=0.034). Results were similar when analyses were done for men and women separately.

TABLE 4.

Relation of Combinations of Variables to Hawaii–Japan Difference in Plasma Fibrinogen

Model Variables in Multiple Linear Regression Model Fibrinogen
1 Site (Hawaii/Japan), age, gender 42.2* (<0.001)
2 Model 1+BMI, kg/m2 33.6 (<0.001)
−20.4%
3 Model 2+iron, mg/1000 kcal 24.9 (<0.001)
−41.0%
4 Model 3+estimated total sugars, %kcal 18.0 (0.019)
−57.3%
5 Model 4+caffeine, mg/1000 kcal 16.3 (0.034)
−61.3%
6§ Model 5+current smoking, urinary Na/K ratio 17.9 (0.020)
−57.6%
*

Coefficient for difference in fibrinogen (mg/dL) between Hawaii and Japan

P value for site-fibrinogen coefficient

percent reduction in site-fibrinogen coefficient compared with model 1

§

nine variables in model 6 (site, age, gender, BMI, iron, estimated total sugars, caffeine, current smoking, and urinary Na/K ratio) were selected in the multiple linear regression model by stepwise selection method (P<0.15) from 17 variables shown in Table 3.

Discussion

In this standardized epidemiological study, ancillary to the INTERMAP study, we found significantly higher plasma fibrinogen levels in both Japanese-American men and women living in Hawaii compared with those of native Japanese. Multiple linear regression models showed that 61.3% of the fibrinogen difference was explained by higher BMI and higher intake of iron, sugar, and caffeine in Hawaii. Neither laboratory errors nor genetic differences appear to be responsible for the fibrinogen difference because quality control procedure assured high comparability of fibrinogen measurements, and the 2 study populations had a common genetic background.

A strength of this study is that data on nutrient intakes were from INTERMAP, a highly standardized international cooperative study on macronutrients and micronutrients and blood pressure. These data were from state-of-the-art nutritional surveys involving 4 in-depth 24-hour dietary recalls per person using comprehensive high-quality comparable databases on the nutrient composition of all reported foods from the 4 countries.1015

Lower plasma fibrinogen levels have been reported in native Japanese compared with white Americans16,17 and with Japanese-Americans.9 The gender-specific magnitudes of the fibrinogen difference in this study were similar to these found previously. These studies tried to identify factors explaining the fibrinogen difference and reported that higher BMI contributed strongly to the difference. However, a large part of the difference could not be explained; further studies on dietary factors were suggested. In the present study, we again demonstrated that obesity was responsible for a sizable part (≈20%) of the fibrinogen difference and further recorded independent additional influences of dietary iron, sugars, and caffeine.

Free iron catalyzes free radical production, which generates a range of potent oxidants that can induce oxidation of lipids.18,19 This pathway has been suggested as a possible explanation of the higher incidence of CHD in men than in premenopausal women because ferritin concentrations are 3× higher in men than in premenopausal women.20,21 A Finnish cohort study reported that higher stored iron level and higher dietary iron intake were significant risk factors for CHD.22 In our study, higher dietary iron intake of Hawaiian Japanese-Americans substantially explained the fibrinogen difference, independently of other nutrient intakes, BMI, and other possible confounders. To the best of our knowledge, there is no previous report on a relationship between iron intake and plasma fibrinogen;23 a recent cross-sectional study in the United States found a positive relationship between ferritin, an indicator of body iron stores, and C-reactive protein, a marker of inflammation.24 The authors hypothesized that iron-catalyzed oxidation of low-density lipoprotein is an important step in the development of inflammation and that such a mechanism may exist for another marker of inflammation: fibrinogen. Thus, the higher incidence of CHD in Western countries may be partly attributable to higher iron intake, causing higher fibrinogen level.

Our study suggested a substantial contribution of higher total sugar intake to higher fibrinogen levels in Hawaii. To the best of our knowledge, there is no previous report on a relationship between sugar intake and plasma fibrinogen.23 A recent study reported an association between high dietary glycemic load and elevated C-reactive protein.25 Inflammation may result from recurrent postprandial hyperglycemia, hyperinsulinemia, and insulin resistance that may occur with long-term high dietary glycemic load.26 Therefore, foods with higher glycemic index, including sugars, may be related to elevated fibrinogen.

Findings on the relationship of caffeine consumption with plasma fibrinogen have been inconsistent.23 Findings on coffee or tea consumption tend to be confounded because coffee and tea contain other nutrients such as flavonoids. Further studies on caffeine and fibrinogen are needed. Some previous studies showed an inverse association between omega-3 PFA and plasma fibrinogen, although these findings have been inconsistent.23 In our study, higher omega-3 PFA intake in Japanese in Japan did not independently explain lower fibrinogen levels in Japan. This may be because of a relatively small difference in omega-3 PFA intake across the samples from Japan and Hawaii, with fish intake relatively high at both sites.

Limitations of these findings are as follows. First, the study design was cross-sectional. Thus, some high-risk individuals may have changed their diet. For example, obese people, whose fibrinogen levels are higher, may have reduced their sugar intake. This would have led to underestimation of the relationship between sugar intake and fibrinogen. Second, other markers of inflammation (eg, C-reactive protein, coagulation, and fibrinolysis) were not measured. Third, nutrient intakes were evaluated from 4 24-hour dietary recalls done in close proximity, hence the data may not fully represent long-term nutrient intake of some individuals.

As to possible practical implications of these findings, the INTERMAP study demonstrated that iron intake was similarly high in its 7 other US samples.15 A US national survey found that 31% of iron intake was from meat sources.27 A recent INTERMAP report also showed that dietary supplement users ingest iron at levels 5- to 6-fold above estimated average requirement.28 High iron intake from meats and supplements may be problematic. High sugar intake from sweets and drinks in the United States has been repeatedly designated a remedial behavior adverse to health (eg, in relation to obesity). Importance of reducing this excess sugar intake may be a valuable public health implications of our study. Similarly, high caffeine intake from coffee, tea, soft drinks, etc, is amenable to reduction.

In conclusion, it was shown in this highly standardized epidemiological study performed as a part of the INTERMAP study that plasma fibrinogen levels in Japanese-Americans living in Hawaii are higher than in native Japanese and that >60% of this difference is attributable to higher intakes of iron, sugar, and caffeine in Hawaii, and to obesity. These dietary factors may, through their influence on fibrinogen, partly explain the large difference in CHD risk between Eastern and Western countries, independent of genetic factors.

Acknowledgments

Sources of Funding

This study was partly supported by the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (A), No. 090357003 in Japan and the Suntory Company; the Pacific Research Institute is supported by the Robert Perry Fund and the Hawaii Community Foundation. The INTERMAP Hawaii Center was funded by the National Heart, Lung, and Blood Institute, National Institutes of Health (grant 5-RO1-HL54868-03). The INTERMAP Study is supported by the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (grant 2-RO1-HL50490), as well as national and local agencies in the 4 countries.

Footnotes

Disclosures

None.

Contributor Information

Katsuyuki Miura, Department of Epidemiology and Public Health, Kanazawa Medical University, Ishikawa, Japan.

Hideaki Nakagawa, Department of Epidemiology and Public Health, Kanazawa Medical University, Ishikawa, Japan.

Hirotsugu Ueshima, Department of Health Science, Shiga University of Medical Science, Otsu, Japan.

Akira Okayama, Department of Preventive Cardiology, National Cardiovascular Center, Osaka, Japan.

Shigeyuki Saitoh, Second Department of Internal Medicine, Sapporo Medical University, Japan.

J. David Curb, Pacific Health Research Institute, Honolulu, Hawaii.

Beatriz L. Rodriguez, Pacific Health Research Institute, Honolulu, Hawaii

Kiyomi Sakata, Department of Hygiene and Preventive Medicine, Iwate Medical University, Morioka, Japan.

Nagako Okuda, Department of Health Science, Shiga University of Medical Science, Otsu, Japan.

Katsushi Yoshita, Division of Health and Nutrition Monitoring, National Institute of Health and Nutrition, Tokyo, Japan.

Jeremiah Stamler, Department of Preventive Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Ill.

References

  • 1.Ueshima H Trends in Asia, Worldwide Trends, II. Global Picture of CHD. Oxford, UK: Oxford Press; 2004. [Google Scholar]
  • 2.Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease. Lancet. 1999;353:1547–1557. [DOI] [PubMed] [Google Scholar]
  • 3.Worth RM, Kato H, Rhoads GG, Kagan K, Syme SL. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: mortality. Am J Epidemiol. 1975;102:481–490. [DOI] [PubMed] [Google Scholar]
  • 4.Robertson TL, Kato H, Gordon T, Kagan A, Rhoads GG, Land CE, Worth RM, Belsky JL, Dock DS, Miyanishi M, Kawamoto S. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Coronary heart disease risk factors in Japan and Hawaii. Am J Cardiol. 1977;39:244–249. [DOI] [PubMed] [Google Scholar]
  • 5.Baba S, Pan WH, Ueshima H, Ozawa H, Komachi Y, Stamler R, Ruth K, Stamler J. Blood pressure levels, related factors, and hypertension control status of Japanese and Americans. J Hum Hypertens. 1991;5:317–332. [PubMed] [Google Scholar]
  • 6.Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc. 1998;279:1477–1482. [DOI] [PubMed] [Google Scholar]
  • 7.Sato S, Nakamura M, Iida M, Naito Y, Kitamura A, Okamura T, Nakagawa Y, Imano H, Kiyama M, Iso H, Shimamoto T, Komachi Y. Plasma fibrinogen and coronary heart disease in urban Japanese. Am J Epidemiol. 2000;152:420–423. [DOI] [PubMed] [Google Scholar]
  • 8.Yano K, Grove JS, Chen R, Rodriguez BL, Curb JD, Tracy RP. Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese- American men. Arterioscler Thromb Vasc Biol. 2001;21:1065–1070. [DOI] [PubMed] [Google Scholar]
  • 9.Yano K, Kodama K, Shimizu Y, Chyou PH, Sharp DS, Tracy RP, Rodriguez BL, Curb JD, Kusumi S. Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii. J Clin Epidemiol. 1999;52:1201–1206. [DOI] [PubMed] [Google Scholar]
  • 10.Stamler J, Elliott P, Dennis B, Dyer AR, Kesteloot H, Liu K, Ueshima H, Zhou B; INTERMAP Research Group. INTERMAP: background, aims, design, methods, and descriptive statistics (non-dietary). J Human Hypertens. 2003;17:591–608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Dennis B, Stamler J, Buzzard M, Conway R, Elliott P, Moag-Stahlberg A, Okuda N, Robertson C, Robinson F, Schakel S, Stevens M, Van Heel N, Zhao LC, Zhou BF; INTERMAP Research Group. INTERMAP: the dietary data - process and quality control. J Hum Hypertens. 2003;17:609–622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ueshima H, Okayama A, Saitoh S, Nakagawa H, Rodriguez B, Sakata K, Okuda N, Choudhury SR, Curb JD. Differences in cardiovascular disease risk factors between Japanese in Japan and Japanese-Americans in Hawaii: the INTERLIPID study. J Hum Hypertens. 2003;17:631–639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Schakel SF, Dennis B, Wold C, Conway R, Zhao L, Okuda N, Moag-Stahlberg A, Robertson C, Van Heel N, Buzzard M, Stamler J. Enhancing data on nutrient composition of foods eaten by participants in the INTERMAP study in China, Japan, the United Kingdom, and United States. J Food Comp Anal. 2003;16:395–408. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Yoshita K, Miura K, Okayama A, Okuda N, Schakel SF, Dennis B, Saitoh S, Sakata K, Nakagawa H, Stamlar J, Ueshima H. A validation study on food composition tables for the international cooperative INTERMAP study in Japan. Environ Health Prev Med. 2005;10:150–156. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Zhou BF, Stamler J, Dennis B, Moag-Stahlberg A, Okuda N, Robertson C, Zhao L, Chan Q, Elliot P; INTERMAP Research Group. Nutrient intakes of middle-aged men and women in China, Japan, United Kingdom, and United States in the late 1990s: the INTERMAP Study. J Hum Hypertens. 2003;17:623–630. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Iso H, Folsom AR, Wu KK, Finch A, Munger RG, Sato S, Shimamoto T, Terao A, Komachi Y. Hemostatic variables in Japanese and Caucasian men: plasma fibrinogen, factor VIIc, factor VIIIc, and von Willebrand factor and their relations to cardiovascular disease risk factors. Am J Epidemiol. 1989;130:925–934. [DOI] [PubMed] [Google Scholar]
  • 17.Iso H, Folsom AR, Sato S, Wu KK, Shimamoto T, Koike K, Iida M, Komachi Y. Plasma fibrinogen and its correlates in Japanese and US population samples. Arterioscler Thromb. 1993;13:783–790. [DOI] [PubMed] [Google Scholar]
  • 18.McCord JM. Is iron sufficiency a risk factor in ischemic heart disease? Circulation. 1991;83:1112–1114. [DOI] [PubMed] [Google Scholar]
  • 19.Cross CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM, Harman D. Oxygen radicals and human disease. Ann Intern Med. 1987;107:526–545. [DOI] [PubMed] [Google Scholar]
  • 20.Sullivan JL. Iron and the sex difference in heart disease risk. Lancet. 1981;1:1293–1294. [DOI] [PubMed] [Google Scholar]
  • 21.Sullivan JL. The iron paradigm of ischemic heart disease. Am Heart J. 1989;117:1177–1188. [DOI] [PubMed] [Google Scholar]
  • 22.Salonen JT, Nyyssonen K, Korpela H, Tuomilehto J, Seppanen R, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803–811. [DOI] [PubMed] [Google Scholar]
  • 23.Lee KW, Lip GYH. Effects of lifestyle on hemostasis, fibrinolysis, and platelet reactivity: a systematic review. Arch Intern Med. 2003;163: 2368–2392. [DOI] [PubMed] [Google Scholar]
  • 24.Mainous AG III, Wells BJ, Everett CJ, Gill JM, King DE. Association of ferritin and lipids with C-reactive protein. Am J Cardiol. 2004;93:559–562. [DOI] [PubMed] [Google Scholar]
  • 25.Liu S, Manson JE, Buring JE, Stampher MJ, Willett WC, Ridker PM. Relation between a diet with a high glycemic load and plasma concentration of high-sensitivity C-reactive protein in middle-aged women. Am J Clin Nutr. 2002;75:492–498. [DOI] [PubMed] [Google Scholar]
  • 26.O’Riordain MG, Ross JA, Fearon KC, Maingay J, Farouk M, Garden OJ, Carter DC. Insulin and counterregulatory hormones influence acute-phase protein production in human hepatocytes. Am J Physiol. 1995;269: E323–E330. [DOI] [PubMed] [Google Scholar]
  • 27.Murphy SP, Calloway DH. Nutrient intakes of women in NHANES II emphasizing trace minerals, fiber, and phytate. J Am Diet Assoc. 1986; 86:1366–1372. [PubMed] [Google Scholar]
  • 28.Archer SL, Stamler J, Moag-Stahlberg A, Van Horn L, Garside D, Chan Q, Buffington JJ, Dyer AR. Association of dietary supplement use with specific micronutrient intakes among middle-aged American men and women: the INTERMAP study. J Am Diet Assoc. 2005;105:1106–1114. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES